AVADEL PHARMA Stock Price (NASDAQ:AVDL)

Add to My Stocks
$10.36 $0.04 (0.38%) AVDL stock closing price Jul 21, 2017 (Closing)
Prev Close* : $10.40
Market Cap:
$430.81M
Day Low: $10.2
52 Week Low: $8.75
Open: $10.43
Volume: 77922
Day High: $10.52
52 Week High: $15.45
Dividend:
N/A

Latest Stock Market News

Latest Articles

AVADEL PHARMA News - From Partners

AVDL Stockcharts

View AVDL PE ratio, PS ratio stocks charts and compare with peers.
AVDL Chart
Note: Compare AVADEL PHARMA stock price history with the index and industry peers.

AVADEL PHARMA Valuation

PS ratio (
price to sales ratio
)
2.58
PB ratio (
price to book ratio
)
8.29

AVADEL PHARMA Financial Ratios

Asset Turnover
0.83
Receivables Turnover
13.65
Debt to Equity
0.01

AVDL Industry Peers

Company Price Change (%)
Karyopharm Therapeutics (KPTI)9.340.04 (0.43%)
Jounce Theraptc (JNCE)13.40.1 (0.75%)
Bellicum (BLCM)11.830.03 (0.25%)
Nutraceutical International (NUTR)41.650.05 (0.12%)
Merck (MRK)62.630.31 (0.49%)
Acura Pharma (ACUR)0.540 (0%)
Depomed (DEPO)10.60.03 (0.28%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.350.25 (6.1%)
Ignyta (RXDX)9.30.5 (5.68%)
PTC Therapeutics (PTCT)21.441.1 (5.41%)
Xencor (XNCR)23.780.78 (3.39%)
Adamis Pharma (ADMP)4.80.15 (3.23%)
Enanta Pharma (ENTA)37.471.05 (2.88%)
Tetraphase Pharmaceuticals (TTPH)8.090.22 (2.8%)
Top gainers from Medical-Drugs industry
* As of Jul 21, 2017
CompanyPriceChange (%)
Heron Therapeutics (HRTX)16.451.05 (6%)
Aralez Pharma (ARLZ)1.450.07 (4.61%)
ImmunoGen (IMGN)5.660.24 (4.07%)
Catalyst Pharma (CPRX)2.950.1 (3.28%)
Pacira Pharma (PCRX)47.651.5 (3.05%)
BioCryst Pharma (BCRX)5.410.16 (2.87%)
GlycoMimetics (GLYC)11.50.33 (2.79%)
Top losers from Medical-Drugs industry
* As of Jul 21, 2017

AVADEL PHARMA Stock News - Partner Headlines

AVADEL PHARMA Financial Statements

income statement20162015201420132012
Net Sales Or Revenues150.24M173.2M14.77M22.44M26.1M
Net Income-41.27M40.65M-88.92M-42.92M-3.22M
Total Operating Expense141.95M90.82M32.98M39.98M40.26M
view AVADEL PHARMA income statement
balance sheet20162015201420132012
Total Assets245.48M214.97M174.2M116.25M117.31M
Total Liabilities203.41M147.11M149.31M125.76M86.8M
Shareholders Equity42.06M67.86M24.89M-9.51M30.5M
view AVADEL PHARMA balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-21.41M-4.81M--1.69M-8.69M
Net Cash From (Used By) Operating Activities18.9M84.29M-10.61M-20.67M-23.13M
Increase (Decrease) In Prop Plant And Equipment-1.2M-1.62M-1.72M-0.02M-1M
view AVADEL PHARMA cashflow statement

AVADEL PHARMA Stock Message Board

AVADEL PHARMA stock lost -0.1 %, and the last close price as of 20 Jul, 2017 is 10.4 for AVDL stock. Looking at AVADEL PHARMA market capitalization, which currently stands at 430.81M, we can say that AVDL stock is a Small cap stock. AVADEL PHARMA valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: AVADEL PHARMA stock price and AVADEL PHARMA share price mean the same thing. The volume of shares traded stood at 62186 on the last trading day, as is evident from AVADEL PHARMA stock chart, and AVDL stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of AVDL, view AVADEL PHARMA stock price history.